ArticlePloS one2026
Food and feed safety of a novel Vip3C insecticidal protein derived from Paenibacillus spp. for protection of crop plants against key Lepidopteran pests.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacillus thuringiensis insecticidal proteins have been safely and effectively used for several decades as tools for insect pest control either as active ingredients in biopesticides or via transgenic expression in crop plants (GM crops). While the first generations of GM crops in the 1990s expressed only three-domain Cry proteins, GM corn and cotton varieties expressing vegetative insecticidal proteins from the Vip3 class began to be cultivated in the late 2000s (Vip3A). Here we describe a comprehensive food and feed safety assessment of Vip3Cb1, the first member of the Vip3C class to be expressed in commercial varieties of GM crops. Bioinformatic protein safety screens reiterate the placement of Vip3Cb1 as an insecticidal member of the Vip3 protein class and demonstrate a lack of homology to known allergens or toxins. In vitro characterization of the thermal stability and digestive fate demonstrates that dietary exposure to an intact, functional form of Vip3Cb1 is highly unlikely. Vip3Cb1 also showed no measurable effects in an in vivo acute oral toxicity study in mice. By weight of evidence, the bioinformatics assessments, in vitro and in vivo studies, history of safe use, and the previously reported mechanism of action similar to Vip3A collectively demonstrate no indication of a risk of Vip3Cb1 to the health of humans or animals and reinforces the overall safety of the Vip3 class of insecticidal proteins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.